Sponsor
Ludwig-Maximilians - University of Munich
Clinical research sponsor
Clinical trials
60 shownPairing Subjective Patient Rating and DBS ProgrammingNCT07336199 · lead sponsor · 2024-12-02
RECRUITINGGerman Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)NCT06711952 · lead sponsor · 2023-02-01
RECRUITINGAmyloid-β Clearance Mechanisms in Alzheimer's DiseaseNCT05059158 · lead sponsor · 2021-06-01
RECRUITINGPersonalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)NCT07586150 · lead sponsor · 2028-10-01
NOT_YET_RECRUITINGDecision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISIONNCT07514520 · lead sponsor · 2025-10-02
ACTIVE_NOT_RECRUITINGA Qualitative Analysis of Youth Responses to Depression Education Delivered on Social MediaNCT07100548 · lead sponsor · 2025-06-01
COMPLETEDEnhancing Depression Literacy and Reducing Stigma in Adolescents Through Social MediaNCT07061600 · lead sponsor · 2025-04-01
COMPLETEDThe Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer PatientsNCT07126860 · lead sponsor · 2024-05-24
ACTIVE_NOT_RECRUITINGDavos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older AdultsNCT06191952 · lead sponsor · 2023-02-01
UNKNOWNDiabetes Education for Patients With Type 2 Diabetes in TurkmenistanNCT06728501 · lead sponsor · 2022-02-01
COMPLETEDTranscranial Direct Current Stimulation in a Home Treatment Setting for Major DepressionNCT05172505 · lead sponsor · 2022-02-01
UNKNOWNEvaluation of a Website to Improve Depression Literacy in Parents of Adolescents With DepressionNCT05335564 · lead sponsor · 2021-01-20
COMPLETEDWeb-based Self-help Intervention for Adolescents With Acute or Remitted Major Depressive DisorderNCT04994470 · lead sponsor · 2021-01-04
COMPLETEDEvaluation of a Website to Improve Depression Literacy in Adolescents With DepressionNCT05300204 · lead sponsor · 2021-01-04
COMPLETEDFear of Cancer Recurrence in Genitourinary CancerNCT04535921 · lead sponsor · 2019-11-05
COMPLETEDCognitive Reappraisal in Adolescents With Major DepressionNCT03957850 · lead sponsor · 2019-05-27
COMPLETEDEffects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular FunctionNCT03082014 · lead sponsor · 2018-02-22
TERMINATEDActivity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's DiseaseNCT06224920 · lead sponsor · 2017-01-01
COMPLETEDAerobic Exercise for the Improvement of Cognition and Enhancement of Recovery in Post-acute SchizophreniaNCT03466112 · lead sponsor · 2016-06-01
COMPLETEDEfficacy of Social Cognitive Training (SCT) in Recent-onset PsychosisNCT03962426 · lead sponsor · 2016-05-01
UNKNOWNDisorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal CortexNCT02715128 · lead sponsor · 2016-03-01
UNKNOWNGestational Diabetes in Central Asia: Prevalence and ManagementNCT02436551 · lead sponsor · 2015-09-01
COMPLETEDTranscranial Direct Current Stimulation (tDCS) As Treatment for Major DepressionNCT02530164 · lead sponsor · 2015-09-01
COMPLETEDEvaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced DiseaseNCT02622412 · lead sponsor · 2015-03-02
COMPLETEDVASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng TransplantationNCT02225249 · lead sponsor · 2014-10-01
UNKNOWNTranscranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With SchizophreniaNCT01378078 · lead sponsor · 2011-06-01
COMPLETEDObservational Study on Determinants of Dementia After StrokeNCT01334749 · lead sponsor · 2011-04-01
ACTIVE_NOT_RECRUITINGCognition in Breast Cancer Patients: The Impact of Cancer-related StressNCT01264562 · lead sponsor · 2011-01-01
COMPLETEDOutcome Predictors of a Cognitive Intervention in aMCINCT01525368 · lead sponsor · 2010-09-01
COMPLETEDEffect of Sitagliptin on Postprandial Lipoprotein MetabolismNCT00939939 · lead sponsor · 2010-03-01
TERMINATEDNeuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)NCT01150734 · lead sponsor · 2009-10-01
COMPLETEDQuetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed PatientsNCT00953108 · lead sponsor · 2009-09-01
COMPLETEDIloprost in High Risk Cardiac Surgical PatientsNCT00927654 · lead sponsor · 2009-06-01
COMPLETEDStudying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast CancerNCT00670878 · lead sponsor · 2008-06-01
COMPLETEDEffect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes MellitusNCT00551590 · lead sponsor · 2007-12-01
COMPLETEDRegulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsNCT00560430 · lead sponsor · 2007-11-01
COMPLETEDFactor XIII and Pulmonary Embolism in Neurosurgical PatientsNCT01106937 · lead sponsor · 2007-10-01
UNKNOWNEffects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's DiseaseNCT00544856 · lead sponsor · 2007-10-01
COMPLETEDTranscranial Direct Current Stimulation (tDCS) in Treatment-resistant DepressionNCT00667680 · lead sponsor · 2007-03-01
COMPLETEDThe Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)NCT01449019 · lead sponsor · 2006-12-01
COMPLETEDSomatosensory Processing in DepressionNCT00386893 · lead sponsor · 2006-10-01
WITHDRAWNDiffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)NCT00523666 · lead sponsor · 2006-09-01
UNKNOWNSimultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-TrialNCT02181101 · lead sponsor · 2005-09-01
COMPLETEDEffect of Hyperglycemia on Gastric Emptying Interactions With PramlintideNCT00489645 · lead sponsor · 2005-01-01
COMPLETEDGemcitabine + Carboplatin in Breast CancerNCT00450762 · lead sponsor · 2004-03-01
COMPLETEDDopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy SubjectsNCT00166322 · lead sponsor · 2004-01-01
COMPLETEDPopulation Based Intervention to Prevent Obesity in Kindergartens (TigerKids)NCT00336128 · lead sponsor · 2003-10-01
COMPLETEDGemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast CancerNCT00480597 · lead sponsor · 2002-10-01
COMPLETEDEuropean Childhood Obesity Project: Early Programming by Infant Nutrition?NCT00338689 · lead sponsor · 2002-10-01
UNKNOWNCombination Chemotherapy in Treating Women With Breast CancerNCT00047099 · lead sponsor · 2001-08-01
COMPLETEDOptimization of Acute Treatment in First Episode SchizophreniaNCT00157378 · lead sponsor · 2000-11-01
UNKNOWNClinical Trial on Alpha Lipoic Acid in Diabetic Macular EdemaNCT01208948 · lead sponsor · 2000-07-01
COMPLETEDVinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast CancerNCT00433095 · lead sponsor
COMPLETEDStratification and Treatment in Early Psychosis Study - ENHANCENCT06778564 · collaborator · 2026-09-01
RECRUITINGFEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisNCT07645443 · collaborator · 2026-05-27
RECRUITINGImmune Biomarkers in Prostate Cancer Patients Treated With BrachytherapyNCT07131956 · collaborator · 2025-12-01
RECRUITINGThe DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood TuberculosisNCT06593080 · collaborator · 2024-06-01
RECRUITINGClinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric DisordersNCT05656469 · collaborator · 2023-02-23
RECRUITINGExogenous and Endogenous Risk Factors for Early-onset Colorectal CancerNCT05732623 · collaborator · 2022-12-05
RECRUITINGHealth for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding DataNCT07743021 · collaborator · 2021-07-27
RECRUITINGSponsor roles
lead sponsor53
collaborator50
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.